Quantcast

Health Canada Issues Statement Linking Actos to Risk of Bladder Cancer, Announces New Labeling Warning of Actos Side Effects, the Consumer Justice Foundation Reports

April 23, 2012

The Consumer Justice Foundation, a for-profit corporation whose Web site URL can be found at http://www.sideeffectsrx.com, is a team of professional consumer advocates who provide free informational online resources regarding the potential dangers of certain prescription medications. The CJF hereby alerts the public that Health Canada has issued a statement linking the use of Actos to an increased risk of bladder cancer and that the labeling on the packages of this drug will include a warning regarding the risk of Actos side effects that include this disease.

(PRWEB) April 23, 2012

The Consumer Justice Foundation, a for-profit corporation whose team of professional consumer advocates provides free online informational resources to consumers regarding the potential risks associated with the use of certain prescription medications, hereby alerts the public of a statement issued by Health Canada warning of the risks of developing bladder cancer for those who use Actos, a diabetes medication. Health Canada also announced that the labels of this medication would be updated to warn users of the potential for Actos side effects.

Health Canada is a governmental agency that acts in the same role as the FDA does in the United States, and the agency initiated a safety assessment of Actos in June of 2011. The statement regarding the potential risk of developing bladder cancer for those who use this medication and the announcement that the labels of this drug warning of potential Actos side effects is the culmination of this safety assessment.

The manufacturer of Actos, Takeda Canada, Inc. joined in the issuance of this statement and agreed with the recommendation to change the labels of Actos warning of potential Actos side effects. Health Canada came to this conclusion after reviewing the data from an ongoing ten-year study of the drug being performed by Takeda Pharmaceutical. At this point in the trial, 7 out of every 10,000 people who were not using Actos developed bladder cancer. That rate increased to 10 out of every 10,000 people who were using Actos to treat type 2 diabetes.

Health Canada further urged people who have a history of bladder cancer or other bladder-related health problems to use extreme caution when deciding whether or not to use Actos, and it also recommended that people who were currently using Actos to treat the symptoms of type 2 diabetes to consult with their doctors.

About the Consumer Justice Foundation    

The Consumer Justice Foundation, whose Web site can be found at http://www.consumerjusticefoundation.com, is a for-profit organization that serves two purposes for consumers: (1) to provide educational information regarding the policies and procedures of large corporations and how they affect the average consumer; and (2) to provide news updates and resources that continue to update consumers regarding developments taken by corporations that include pharmaceutical drug companies, auto manufacturers and insurance companies so that consumers who have been harmed can use these informational resources to connect to an experienced professional who can help them. The team at the Consumer Justice Foundation is staffed by experienced and passionate consumer advocates whose mission is to raise the awareness of issues that could pose a risk of harm to those who may not otherwise be aware of the dangers they face.

For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2012/4/prweb9426055.htm


Source: prweb



comments powered by Disqus